Stock Events

ENDRA Life Sciences 

$1.12
29
-$0.02-2.18% Today

Statistics

Day High
-
Day Low
-
52W High
4
52W Low
0.87
Volume
66,017
Avg. Volume
83,361
Mkt Cap
12.3M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-1.2
-0.93
-0.67
-0.4
Expected EPS
-0.42
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NDRA. It's not an investment recommendation.

About

Health Technology
Biotechnology
Manufacturing
Surgical and Medical Instrument Manufacturing
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Show more...
CEO
Employees
21
Country
US
ISIN
US29273B1044

Listings